Vericel (VCEL) Total Liabilities (2010 - 2026)
Vericel (VCEL) reported Total Liabilities of $129.4 million for Q1 2026, little changed on a YoY basis from $129.1 million in Q1 2025, and down 2.95% sequentially from $133.3 million in Q4 2025.
Vericel (VCEL) Total Liabilities (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Total Liabilities data on file, last reported at $129.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities changed 0.23% year-over-year to $129.4 million; the trailing twelve-month figure through Mar 2026 stood at $129.4 million (changed 0.23% YoY), and the FY2025 full-year result was $133.3 million, down 5.28% from the prior year.
- Total Liabilities retreated to $129.4 million in Q1 2026, from $133.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $140.8 million in Q4 2024 to a low of $67.8 million in Q1 2022.
- A 5-year average of $111.5 million and a median of $127.7 million in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities soared 72.62% in 2024 and dropped 5.28% in 2025, its largest moves.
- Tracing VCEL's Total Liabilities over 5 years: stood at $80.7 million in 2022, then soared by 58.19% to $127.7 million in 2023, then climbed by 10.22% to $140.8 million in 2024, then retreated by 5.28% to $133.3 million in 2025, then retreated by 2.95% to $129.4 million in 2026.
- Business Quant data shows VCEL's Total Liabilities at $129.4 million in Q1 2026, $133.3 million in Q4 2025, and $131.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 129.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.40 Mn |
| Dec 31, 2025 | 133.33 Mn |
| Sep 30, 2025 | 131.42 Mn |
| Jun 30, 2025 | 128.80 Mn |
| Mar 31, 2025 | 129.10 Mn |
| Dec 31, 2024 | 140.76 Mn |
| Sep 30, 2024 | 132.93 Mn |
| Jun 30, 2024 | 133.86 Mn |
| Mar 31, 2024 | 122.77 Mn |
| Dec 31, 2023 | 127.71 Mn |
| Sep 30, 2023 | 113.75 Mn |
| Jun 30, 2023 | 111.78 Mn |
| Mar 31, 2023 | 71.12 Mn |
| Dec 31, 2022 | 80.73 Mn |
| Sep 30, 2022 | 70.18 Mn |
| Jun 30, 2022 | 70.00 Mn |
| Mar 31, 2022 | 67.80 Mn |
| Dec 31, 2021 | 73.24 Mn |
| Sep 30, 2021 | 67.36 Mn |
| Jun 30, 2021 | 70.85 Mn |